🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07329738
Active, not recruiting Not applicable

Single-Subject Research Design on 3D-Printed Prosthetic Sockets

NCT07329738 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2023-07-17
Last updated
2026-01-09

Condition(s) studied

Transtibial Amputees

Investigational drug(s) / intervention(s)

3D printed prosthetic sockets

3D printed prosthetic sockets: The sockets are 3D printed using Polyethylene Terephthalate Glycol (PETG) filament. The printer used for this process is the Fused Deposition Modelling (Creality Ender 6), equipped with a 1.0 mm nozzle diameter, a print speed of 45mm/s, and a layer thickness of 2 mm. To enhance their strength, the sockets are reinforced with Delta-Lite® plus cast tapes and assembled using a distal push-lock mechanism and plate. The number of reinforcement wraps of the Delta-Lite® differs for each region of the socket. Below the sockets, the same prosthetic components from the previous prosthesis are utilized where possible. Participants wear their 3D printed sockets for an adjustment period (3-7 days) and then come in for a follow-up session to ensure the 3D socket still fits well after their limb has settled into the new system. Once both the prosthetist and participant are happy with the fit, Phase B testing is scheduled.

Study summary

The goal of this single-subject research design (clinical trial) is to assess the functionality of the 3D printed prostheses and to compare them to the existing prostheses in terms of mobility, balance, utility, and comfort. Participants who have a unilateral or bilateral transtibial amputation wear their existing prosthesis for roughly 3 weeks, followed by 3 weeks wearing a 3D printed prosthesis. The research assistants collect data throughout each period remotely, with the exception of one in-person visit to participants' homes to prepare the setting for the virtual evaluation sessions.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * are adults 19+ years, * have a unilateral or bilateral transtibial amputation, * have an existing definitive prosthesis, * use their definitive prosthesis two or more consecutive hours per day, * have no wounds on the residual limb. Exclusion Criteria: * are unable to adequately complete self-report measures or communicate well enough to participate in the end of project interview, * have bilateral upper extremity amputations, * have poorly controlled comorbidities (e.g., unstable diabetes, advanced heart problems)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of British Columbia Vancouver British Columbia

More University of British Columbia trials in Canada

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07329738 on ClinicalTrials.gov ↗ ← All trials in Canada